Covington & Burling advises BioCryst Pharmaceuticals on its acquisition of Astria Therapeutics, with Sidley Austin representing Astria, in a transaction valued at approximately $920 million.
Astria Therapeutics, Inc. sold the stake/assets to BioCryst Pharmaceuticals, Inc. as part of an acquisition.
Deal value was 920000000 (source: Extracted) Sector: Biotechnology; Location: USA.
On the seller side, legal advice was provided by a team including Rosemary Reilly, John Butler, Sally Wagner Partin, Joshua Hofheimer, Elizabeth Burns, Dina M.P. Kang, Amanda Patterson, Nicholas Carballo, Sabrina Glavota, Sophia Iams, Rebecca Nauta, Emily Ivers, Torrey Cope, Donielle McCutcheon, Julea Lipiz, Emily Schneider, Vadim Brusser, Eric Kauffman, Emily M. Wajert, Jonathan M. Westreich, Iris Wang, Steven Rutkovsky, Harsh D. Deshmukh, Stephanie Y. Lim.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Covington & Burling advises BioCryst Pharmaceuticals on its acquisition of Astria Therapeutics, with Sidley Austin representing Astria, in a transaction valued at approximately $920 million. | The Sponsor - The Sponsor
